Literature DB >> 23164616

Synaptic plasticity in the hippocampus shows resistance to acute ethanol exposure in transgenic mice with astrocyte-targeted enhanced CCL2 expression.

Jennifer G Bray1, Kenneth C Reyes, Amanda J Roberts, Richard M Ransohoff, Donna L Gruol.   

Abstract

It has been shown that ethanol exposure can activate astrocytes and microglia resulting in the production of neuroimmune factors, including the chemokine CCL2. The role of these neuroimmune factors in the effects of ethanol on the central nervous system has yet to be elucidated. To address this question, we investigated the effects of ethanol on synaptic transmission and plasticity in the hippocampus from mice that express elevated levels of CCL2 in the brain and their non-transgenic littermate controls. The brains of the transgenic mice simulate one aspect of the alcoholic brain, chronically increased levels of CCL2. We used extracellular field potential recordings in acutely isolated hippocampal slices to identify neuroadaptive changes produced by elevated levels of CCL2 and how these neuroadaptive changes affect the actions of acute ethanol. Results showed that synaptic transmission and the effects of ethanol on synaptic transmission were similar in the CCL2-transgenic and non-transgenic hippocampus. However, long-term potentiation (LTP), a cellular mechanism thought to underlie learning and memory, in the CCL2-transgenic hippocampus was resistant to the ethanol-induced depression of LTP observed in the non-transgenic hippocampus. Consistent with these results, ethanol pretreatment significantly impaired cued and contextual fear conditioning in non-transgenic mice, but had no effect in CCL2-transgenic mice. These data show that chronically elevated levels of CCL2 in the hippocampus produce neuroadaptive changes that block the depressing effects of ethanol on hippocampal synaptic plasticity and support the hypothesis that CCL2 may provide a neuroprotective effect against the devastating actions of ethanol on hippocampal function.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23164616      PMCID: PMC3595200          DOI: 10.1016/j.neuropharm.2012.11.007

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  75 in total

1.  Age and dose-dependent effects of ethanol on the induction of hippocampal long-term potentiation.

Authors:  G K Pyapali; D A Turner; W A Wilson; H S Swartzwelder
Journal:  Alcohol       Date:  1999-10       Impact factor: 2.405

2.  Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.

Authors:  R G Phillips; J E LeDoux
Journal:  Behav Neurosci       Date:  1992-04       Impact factor: 1.912

3.  Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task.

Authors:  S F Logue; R Paylor; J M Wehner
Journal:  Behav Neurosci       Date:  1997-02       Impact factor: 1.912

4.  Acute effects of ethanol on hippocampal long-term potentiation and long-term depression are mediated by different mechanisms.

Authors:  Y Izumi; K Nagashima; K Murayama; C F Zorumski
Journal:  Neuroscience       Date:  2005-10-10       Impact factor: 3.590

5.  Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices.

Authors:  Yan Zhou; Hongmei Tang; Jianuo Liu; Jun Dong; Huangui Xiong
Journal:  J Neurochem       Date:  2010-12-13       Impact factor: 5.372

6.  Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice.

Authors:  Deren Huang; Jerome Wujek; Graham Kidd; Toby T He; Astrid Cardona; Margaret E Sasse; Erica J Stein; Jacqueline Kish; Marie Tani; Israel F Charo; Amanda E Proudfoot; Barrett J Rollins; Tracy Handel; Richard M Ransohoff
Journal:  FASEB J       Date:  2005-05       Impact factor: 5.191

7.  MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis.

Authors:  E A Eugenin; T G D'Aversa; L Lopez; T M Calderon; J W Berman
Journal:  J Neurochem       Date:  2003-06       Impact factor: 5.372

8.  Activity of adenosine receptors type 1 Is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons.

Authors:  Clotilde Lauro; Silvia Di Angelantonio; Raffaela Cipriani; Fabrizia Sobrero; Letizia Antonilli; Valentina Brusadin; Davide Ragozzino; Cristina Limatola
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

9.  Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline.

Authors:  Jose L M Madrigal; Juan C Leza; Paul Polak; Sergey Kalinin; Douglas L Feinstein
Journal:  J Neurosci       Date:  2009-01-07       Impact factor: 6.167

10.  SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum.

Authors:  C Limatola; A Giovannelli; L Maggi; D Ragozzino; L Castellani; M T Ciotti; F Vacca; D Mercanti; A Santoni; F Eusebi
Journal:  Eur J Neurosci       Date:  2000-07       Impact factor: 3.386

View more
  24 in total

Review 1.  Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?

Authors:  Mark J Niciu; Ioline D Henter; Gerard Sanacora; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-12       Impact factor: 4.132

Review 2.  Modulation of learning and memory by cytokines: signaling mechanisms and long term consequences.

Authors:  Elissa J Donzis; Natalie C Tronson
Journal:  Neurobiol Learn Mem       Date:  2014-08-21       Impact factor: 2.877

Review 3.  The neuroimmune transcriptome and alcohol dependence: potential for targeted therapies.

Authors:  Anna Warden; Emma Erickson; Gizelle Robinson; R Adron Harris; R Dayne Mayfield
Journal:  Pharmacogenomics       Date:  2016-12-05       Impact factor: 2.533

Review 4.  Ethanol and Cytokines in the Central Nervous System.

Authors:  Marisa Roberto; Reesha R Patel; Michal Bajo
Journal:  Handb Exp Pharmacol       Date:  2018

5.  Altered hippocampal synaptic function in transgenic mice with increased astrocyte expression of CCL2 after withdrawal from chronic alcohol.

Authors:  Jennifer G Bray; Kenneth C Reyes; Amanda J Roberts; Donna L Gruol
Journal:  Neuropharmacology       Date:  2018-02-27       Impact factor: 5.250

6.  Transgenic mice with increased astrocyte expression of CCL2 show altered behavioral effects of alcohol.

Authors:  Jennifer G Bray; Amanda J Roberts; Donna L Gruol
Journal:  Neuroscience       Date:  2017-04-19       Impact factor: 3.590

7.  Transgenic mice with increased astrocyte expression of IL-6 show altered effects of acute ethanol on synaptic function.

Authors:  Ruben V Hernandez; Alana C Puro; Jessica C Manos; Salvador Huitron-Resendiz; Kenneth C Reyes; Kevin Liu; Khanh Vo; Amanda J Roberts; Donna L Gruol
Journal:  Neuropharmacology       Date:  2015-12-17       Impact factor: 5.250

8.  Effects of ethanol on immune response in the brain: region-specific changes in adolescent versus adult mice.

Authors:  Cynthia J M Kane; Kevin D Phelan; James C Douglas; Gail Wagoner; Jennifer W Johnson; Jihong Xu; Patrick S Phelan; Paul D Drew
Journal:  Alcohol Clin Exp Res       Date:  2013-08-22       Impact factor: 3.455

9.  Adolescent Intermittent Alcohol Exposure: Dysregulation of Thrombospondins and Synapse Formation are Associated with Decreased Neuronal Density in the Adult Hippocampus.

Authors:  Mary-Louise Risher; Hannah G Sexton; W Christopher Risher; Wilkie A Wilson; Rebekah L Fleming; Roger D Madison; Scott D Moore; Cagla Eroglu; H Scott Swartzwelder
Journal:  Alcohol Clin Exp Res       Date:  2015-11-05       Impact factor: 3.455

Review 10.  Glial mechanisms underlying substance use disorders.

Authors:  K E Linker; S J Cross; F M Leslie
Journal:  Eur J Neurosci       Date:  2018-10-22       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.